$MIST

$0.76 +$0.07 (9.58%) Close

$MIST Overview Financial Statements SEC Filings Executives News Red Flags Capital Raising Ownership Insider Transactions Congressional Trades

Ownership

13F as of Q2 2026 · 124.5M shares outstanding

Who owns MIST?

By type of holder

Institutions 39.5% Insiders 0.9% Everyone else 59.6%

Concentration Top 10 holders own 33.4%

Pavaki Capital Management LLC 7.3% · RTW Investments, LP 6.3%

Institutional ownership

39.5%

+7.8 pts vs last qtr

Institutional holders

-9 vs last qtr

Net shares bought

+9.7M

by institutions in Q2 2026

New / sold out

6 / 15

positions opened vs closed

How is ownership changing?

Institutions, last 8 quarters

Biggest buyers in Q2 2026

Point72 Asset Management, L.P. +4.3M
Propel Bio Management, LLC +3.3M

Biggest sellers in Q2 2026

Goldman Sachs Group Inc SOLD OUT −2.0M
Balyasny Asset Management L.P. −630.8K

Who is planning to sell?

Notices of proposed sale, last 12 months

$252K

3 notices from 1 person

Shares covered

116.5K

0.09% of the company

Arranged in advance

100%

of the value is under a 10b5-1 plan

Under a 10b5-1 plan No plan

Largest proposed sellers

Joseph Oliveto Director 10b5-1 $252K

Every notice on Red Flags →

A Form 144 is notice of a planned sale, not the sale itself. What insiders actually sold is on Insider Transactions.

Is your stake being diluted?

There are not yet two fiscal years of reported share counts for Milestone Pharmaceuticals Inc.

How patient are the owners?

Institutional shares by how long they've been held

5+ years17% 3–5 years2% 1–3 years25% Under 1 year55%

Quarterly turnover

24.9%

of institutional shares changed hands

Top 10 managers, median time held

3 quarters

Super Investors

Investment managers reporting MIST on Form 13F

Holder	Shares	% of company	Change vs last qtr	Held since	% of their book
PC Pavaki Capital Management LLC	9.1M	7.28%	+5.0K (+0.1%)	Q4 '25	4.2%
Shares held by quarter Peak holding9.1M (Q2'26) Change over 8 quarters+9.1M Share of the company7.280% Pavaki Capital Management LLC's full portfolio →
RI RTW Investments, LP	7.8M	6.29%	+1.5M (+23.7%)	≤2021	0.1%
Shares held by quarter Peak holding7.8M (Q2'26) Change over 8 quarters+4.6M Share of the company6.290% RTW Investments, LP's full portfolio →

Pavaki Capital Management LLC

9.1M

% of company

7.28%

Change vs last qtr

+5.0K (+0.1%)

Held since

Q4 '25

RTW Investments, LP

7.8M

% of company

6.29%

Change vs last qtr

+1.5M (+23.7%)

Held since

≤2021

28 more super investors behind a free account

See every manager holding Milestone Pharmaceuticals Inc, how their position has changed, and how long they've held it.

Institutional Funds

Mutual funds and ETFs reporting MIST on Form N-PORT; together they hold 2.8% of the company

Fund	Position value	Shares	% of company	% of the fund	As of
SP Simplify Propel Opportunities ETF Simplify Exchange Traded Funds	$4.49M	3.3M	2.69%	5.81%	June 30, 2026
IN Invesco NASDAQ Future Gen 200 ETF Invesco Exchange-Traded Fund Trust II	$63.8K	44.9K	0.04%	0.34%	May 31, 2026

Simplify Propel Opportunities ETF

Simplify Exchange Traded Funds

Position value

$4.49M

% of company

2.69%

% of the fund

5.81%

As of

June 30, 2026

Invesco NASDAQ Future Gen 200 ETF

Invesco Exchange-Traded Fund Trust II

Position value

$63.8K

% of company

0.04%

% of the fund

0.34%

As of

May 31, 2026

3 more funds behind a free account

See every fund holding Milestone Pharmaceuticals Inc and how much of the fund the position is.

Insiders and 5%+ holders

From Forms 3/4/5 and Schedules 13D/G

Holder	Shares	% of company	Change vs last qtr	8 quarters	Held since	% of their book
OJ Oliveto Joseph Insider	446.2K	0.36%	—	—	—	—
Insider holdings come from Form 3/4/5 filings, which are not quarterly. Share of the company0.360% Oliveto Joseph's insider activity →
ML Muller Lorenz Insider	205.4K	0.16%	—	—	—	—
Insider holdings come from Form 3/4/5 filings, which are not quarterly. Share of the company0.160% Muller Lorenz's insider activity →

Oliveto Joseph

Insider

446.2K

% of company

0.36%

Change vs last qtr

—

Held since

—

Muller Lorenz

Insider

205.4K

% of company

0.16%

Change vs last qtr

—

Held since

—

6 more holders behind a free account

See every insider and 5%+ holder of Milestone Pharmaceuticals Inc.

Comments